A Study of Vemurafenib in Participants With Metastatic Melanoma

NCT ID: NCT01307397

Last Updated: 2017-12-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

3219 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-01

Study Completion Date

2016-02-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multi-center study evaluates the safety and efficacy of vemurafenib in participants with BRAF V600 mutation-positive, surgically incurable, and unresectable Stage IIIC or IV (American Joint Committee on Cancer \[AJCC\]) metastatic melanoma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malignant Melanoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vemurafenib

Participants will receive vemurafenib at a dose of 960 milligrams (mg) twice daily (bid) until the development of progressive disease, unacceptable toxicity, consent withdrawal, protocol violations endangering participant's safety, death, or study termination by the Sponsor, whichever occurs first.

Group Type EXPERIMENTAL

Vemurafenib

Intervention Type DRUG

Participants will receive continuous oral doses of vemurafenib 960 mg (four 240 mg tablets) twice daily in each 28-day treatment cycle until the development of progressive disease, unacceptable toxicity, consent withdrawal, protocol violations endangering participant's safety, death, or study termination by the Sponsor, whichever occurs first.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vemurafenib

Participants will receive continuous oral doses of vemurafenib 960 mg (four 240 mg tablets) twice daily in each 28-day treatment cycle until the development of progressive disease, unacceptable toxicity, consent withdrawal, protocol violations endangering participant's safety, death, or study termination by the Sponsor, whichever occurs first.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

RO5185426, Zelboraf

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants with Histologically confirmed metastatic melanoma (surgically incurable and unresectable Stage IIIC or Stage IV; AJCC) with BRAF V 600 mutation determined by Cobas 4800 BRAF Mutation Test. Unresectable Stage IIIC disease must have had confirmation from a surgical oncologist
* Participants with either measurable or non-measurable disease according to Response Evaluation Criteria in Solid Tumours (RECIST) Version 1.1
* Participants may or may not have received prior systemic therapy for metastatic melanoma
* Eastern Cooperative Oncology Group (ECOG) performance status between 0 to 2
* Adequate hematologic, renal and liver function

Exclusion Criteria

* Evidence of symptomatic central nervous system (CNS) lesions, use of steroids or anti-seizure medications for treatment of brain metastases prior to the first administration of vemurafenib
* Previous malignancy (other than melanoma) within the past 2 years, except for treated and controlled basal or squamous cell carcinoma of the skin or carcinoma in-situ of the cervix
* Concurrent administration of any anti-cancer therapies other than those administered in the study
* Clinically significant cardiovascular disease or event within the 6 months prior to first administration of study drug
* Refractory nausea or vomiting, external biliary shunt, or significant bowel resection that would preclude adequate absorption
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University "Mother Theresa" Hospital Center; Oncology Department

Tirana, , Albania

Site Status

Hospital Britanico; Oncologia

Buenos Aires, , Argentina

Site Status

Fundación CIDEA

Buenos Aires, , Argentina

Site Status

Inst. Alexander Fleming; Oncologia

Buenos Aires, , Argentina

Site Status

Melanoma Institute Australia

North Sydney, New South Wales, Australia

Site Status

Newcastle Mater Misericordiae Hospital; Oncology

Waratah, New South Wales, Australia

Site Status

Westmead Hospital

Westmead, New South Wales, Australia

Site Status

Border Medical Oncology

Wodonga, New South Wales, Australia

Site Status

Greenslopes Private Hospital; Gallipoli Research Centre

Greenslopes, Queensland, Australia

Site Status

The Townsville Hospital; Townsville Cancer Centre

Townsville, Queensland, Australia

Site Status

Princess Alexandra Hospital Woolloongabba; Clinical Hematology and Medical Oncology

Woolloongabba, Queensland, Australia

Site Status

Royal Adelaide Hospital; Oncology

Adelaide, South Australia, Australia

Site Status

Geelong Hospital; Geelong Cardiology Practice

Geelong, Victoria, Australia

Site Status

Peter MacCallum Cancer Centre; Medical Oncology

Melbourne, Victoria, Australia

Site Status

Alfred Hospital

Melbourne, Victoria, Australia

Site Status

Sir Charles Gairdner Hospital

Nedlands, Western Australia, Australia

Site Status

Landeskrankenhaus Feldkirch; Abteilung für Innere Medizin

Feldkirch, , Austria

Site Status

LKH Graz; Abteilung für allgemeine Dermatologie

Graz, , Austria

Site Status

LKH Innsbruck; Universitätsklinik für Dermatologie

Innsbruck, , Austria

Site Status

Krankenhaus der Elisabethinen Linz; Abteilung für Dermatologie

Linz, , Austria

Site Status

Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt.

Salzburg, , Austria

Site Status

LKH Salzburg; Universitätsklinik für Dermatologie

Salzburg, , Austria

Site Status

Landesklinikum St. Pölten

Sankt Pölten, , Austria

Site Status

Medizinische Universität Wien; Univ.Klinik für Dermatologie

Vienna, , Austria

Site Status

UZ Brussel

Brussels, , Belgium

Site Status

Cliniques Universitaires St-Luc

Brussels, , Belgium

Site Status

Sint Augustinus Wilrijk

Wilrijk, , Belgium

Site Status

University Clinical Center of the Republic of Srpska

Banja Luka, , Bosnia and Herzegovina

Site Status

Clinic of Oncology, University Clinical Center Sarajevo

Sarajevo, , Bosnia and Herzegovina

Site Status

Instituto Nacional de Cancer - INCa; Pesquisa Clinica

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Hospital das Clinicas - UFRGS

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Instituto do Cancer do Estado de Sao Paulo - ICESP

São Paulo, São Paulo, Brazil

Site Status

Hospital A. C. Camargo; Oncologia

São Paulo, São Paulo, Brazil

Site Status

Hospital Sao Jose

São Paulo, São Paulo, Brazil

Site Status

District Oncology Dispensary; Department for Oncology and Dermatology

Plovdiv, , Bulgaria

Site Status

National Specialized Hospital for Active Oncology Treatment; Dermatology Clinic

Sofia, , Bulgaria

Site Status

Cross Cancer Institute ; Dept of Medical Oncology

Edmonton, Alberta, Canada

Site Status

Lion'S Gate Hospital

North Vancouver, British Columbia, Canada

Site Status

British Columbia Cancer Agency (Bcca) - Vancouver Cancer Centre

Vancouver, British Columbia, Canada

Site Status

St. Boniface General Hospital; Medicine

Winnipeg, Manitoba, Canada

Site Status

QEII HSC; Oncology

Halifax, Nova Scotia, Canada

Site Status

Hamilton Health Sciences - Juravinski Cancer Centre

Hamilton, Ontario, Canada

Site Status

London Regional Cancer Centre

London, Ontario, Canada

Site Status

The Ottawa Hospital; Division of Infectious Diseases

Ottawa, Ontario, Canada

Site Status

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Site Status

University Health Network; Princess Margaret Hospital; Medical Oncology Dept

Toronto, Ontario, Canada

Site Status

McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology

Montreal, Quebec, Canada

Site Status

Chuq - Hopital Hotel Dieu de Quebec; Oncology

Québec, Quebec, Canada

Site Status

Centro Javeriano de Oncología

Bogotá, , Colombia

Site Status

Fundacion Santa Fe de Bogotá

Bogotá, , Colombia

Site Status

Clínica Imbanaco; Oncology

Cali, , Colombia

Site Status

Hospital Pablo Tobon Uribe

Medellin-Antioquia, , Colombia

Site Status

Clinical Hospital Sisters of Mercy

Zagreb, , Croatia

Site Status

Masarykův onkologický ústav; Klinika komplexní onkologické péče

Brno, , Czechia

Site Status

University Hospital; Oncology and Radiotherapy

Hradec Králové, , Czechia

Site Status

Fakultni nemocnice Olomouc; Onkologicka klinika

Olomouc, , Czechia

Site Status

Faculty Hospital; Dialysis Unit

Ostrava, , Czechia

Site Status

1 Lekarska Fakulta Uni Karlovy; 3 Interni Klinika, Labor. Pro Endokrinologii A Metabolismus

Prague, , Czechia

Site Status

Faculty Hospital Kralovske Vinohrady; Oncology

Prague, , Czechia

Site Status

Aarhus Universitetshospital; Kræftafdelingen

Aarhus C, , Denmark

Site Status

Herlev Hospital; Onkologisk afdeling

Herlev, , Denmark

Site Status

Odense Universitetshospital, Onkologisk Afdeling R

Odense, , Denmark

Site Status

Hospital Regional Vicente Corral Moscoso, Servicio de Oncología

Cuenca, , Ecuador

Site Status

Hospital Abel Gilbert Ponton; Oncology

Guayaquil, , Ecuador

Site Status

Hospital Solca Portoviejo; Oncologia

Portoviejo, , Ecuador

Site Status

East Tallinn Central Hospital; Clinic of Internal Medicine

Tallinn, , Estonia

Site Status

North Estonia Medical Centre Foundation; Oncology Center

Tallinn, , Estonia

Site Status

Tartu University Hospital; Clinic of Hematology and Oncology

Tartu, , Estonia

Site Status

Helsinki University Central Hospital; Dept of Oncology

Helsinki, , Finland

Site Status

Tampere University Hospital; Dept of Oncology

Tampere, , Finland

Site Status

Turku Uni Central Hospital; Oncology Clinics

Turku, , Finland

Site Status

Uniklinik RWTH Aachen; Klinik für Dermatologie und Allergologie - Hautklinik

Aachen, , Germany

Site Status

Klinikum Augsburg Süd; Klinik für Dermatologie und Allergologie

Augsburg, , Germany

Site Status

CAMPUS BENJAMIN FRANKLIN CharitéCentrum 14 Med.Klinik f.Hämatologie u.Onkologie

Berlin, , Germany

Site Status

St. Josef-Hospital Klinik f. Dermatologie u. Allergologie

Bochum, , Germany

Site Status

Elbekliniken Buxtehude; Klinik für Dermatologie

Buxtehude, , Germany

Site Status

DRK-Krankenhaus; Hautklinik

Chemnitz, , Germany

Site Status

Klinik der Uni zu Köln; Klinik & Poliklinik fuer Dermatologie & Venerologie

Cologne, , Germany

Site Status

Universitätsklinikum "Carl Gustav Carus"; Medizinische Klinik und Poliklinik I

Dresden, , Germany

Site Status

Universitätsklinikum Düsseldorf; Hautklinik

Düsseldorf, , Germany

Site Status

HELIOS Klinikum Erfurt, Klinik für Hautkrankheiten und Allergologie

Erfurt, , Germany

Site Status

Universitätsklinikum Erlangen; Hautklinik

Erlangen, , Germany

Site Status

Universitätsklinikum Essen

Essen, , Germany

Site Status

Klinik Johann Wolfgang von Goethe Uni; Klinik fuer Allgemein- und Viszeralchirurgie

Frankfurt, , Germany

Site Status

Uniklinikum Freiburg Dermatol

Freiburg im Breisgau, , Germany

Site Status

SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie

Gera, , Germany

Site Status

Universitätsmedizin Göttingen Georg-August-Universität Zentrum Dermatologie

Göttingen, , Germany

Site Status

Universitätsklinikum Hamburg-Eppendorf Zentrum f.Innere Medizin Klinik f.Dermatologie

Hamburg, , Germany

Site Status

Medizinische Hochschule; Hautklinik Linden

Hanover, , Germany

Site Status

Uni-Hautklinik

Heidelberg, , Germany

Site Status

Klinikum am Gesundbrunnen; Tumorzentrum

Heilbronn, , Germany

Site Status

Universitätsklinikum Jena; Klinik für Hautkrankheiten

Jena, , Germany

Site Status

Klinikum Kassel; Hautklinik

Kassel, , Germany

Site Status

UNI-Klinikum Campus Kiel Klinik f.Dermatologie Tagesklinik f.Dermatologie

Kiel, , Germany

Site Status

Universitätsklinikum Leipzig Klinik f.Dermatologie Venerologie u.Allergologie

Leipzig, , Germany

Site Status

Klinikum d.Stadt Ludwigshafen Hautklinik

Ludwigshafen, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein; Campus Lübeck

Lübeck, , Germany

Site Status

Universitätsklinikum Magdeburg; Hautklinik; Klinik für Dermatologie und Venerologie

Magdeburg, , Germany

Site Status

Johannes Gutenberg Unis-Klinik; Dept For Dermatology

Mainz, , Germany

Site Status

Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie

Mannheim, , Germany

Site Status

Universitätsklinikum Marburg Klinik f. Dermatologie

Marburg, , Germany

Site Status

Johannes-Wesling-Klinikum Minden; Onkologische Ambulanz / Tagesklinik

Minden, , Germany

Site Status

Klinikum der LMU München; Klinik und Poliklinik für Dermatologie und Allergologie

München, , Germany

Site Status

Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie

München, , Germany

Site Status

Universitätsklinikum Münster

Münster, , Germany

Site Status

Fachklinik Hornheide; Internistische Onkologie

Münster, , Germany

Site Status

Klinikum Nürnberg Nord; Hautklinik; Klinik für Dermatologie

Nuremberg, , Germany

Site Status

Klinikum Dorothea Ch.Erxleben; Klinik für Dermatologie und Allergologie

Quedlinburg, , Germany

Site Status

KLINIKUM VEST GmbH Knappschaftskrankenhaus Abt.Haut- Allergie- Venen- und Umwelterkrankungen

Recklinghausen, , Germany

Site Status

Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie

Regensburg, , Germany

Site Status

Universitaets-Hautklinik Tuebingen

Tübingen, , Germany

Site Status

Wilhelm Fresenius Klinik; Klinik f. Dermatologie u. Allergologie

Wiesbaden, , Germany

Site Status

HELIOS Klinikum Barmen Zentrum Dermatologie Allergologie und Umweltmedizin

Wuppertal, , Germany

Site Status

Universitätsklinikum Würzburg; Klinik und Poliklinik für Dermatologie Venerologie u. Allergologie

Würzburg, , Germany

Site Status

Laiko General Hospital; 1St Pathological Clinic

Athens, , Greece

Site Status

Hospital Hygeia; 1St Oncology Dept.

Athens, , Greece

Site Status

Univ General Hosp Heraklion; Medical Oncology

Heraklion, , Greece

Site Status

Metropolitan Hospital; Dept. of Oncology

Piraeus, , Greece

Site Status

Semmelweis Egyetem; Bor-, Nemikortani es Boronkologiai Klinika

Budapest, , Hungary

Site Status

Orszagos Onkologiai Intezet; B Belgyogyaszati Osztaly

Budapest, , Hungary

Site Status

Debreceni Egyetem OEC; Borgyogyaszati Klinika

Debrecen, , Hungary

Site Status

Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika

Pécs, , Hungary

Site Status

Szegedi Tud.Egyetem Szent-Gyorgyi Albert Klin.Kozp.

Szeged, , Hungary

Site Status

Tata Memorial Hospital; Dept of Medical Oncology

Mumbai, Maharashtra, India

Site Status

Curie Manavata Cancer Centre

Nashik, Maharashtra, India

Site Status

Rajiv Gandhi Cancer Inst.&Research Center; Medical Oncology

New Delhi, National Capital Territory of Delhi, India

Site Status

Basavatarakam Indo-American Cancer Hospital & Research Institute

Hyderabad, , India

Site Status

Chhatrapati Shahuji Maharaj Medical University; Department of Oncology

Lucknow, , India

Site Status

Regional Cancer Centre; Dept of Oncology

Trivandrum, , India

Site Status

Christian Med Clg & Hspt

Vellore, , India

Site Status

Cork Uni Hospital; Oncology Dept

Cork, , Ireland

Site Status

St Vincent'S Uni Hospital; Medical Oncology

Dublin, , Ireland

Site Status

Mater Misericordiae Uni Hospital; Oncology

Dublin, , Ireland

Site Status

Mater Private Hospital

Dublin, , Ireland

Site Status

St James' Hospital; Cancer Clinical Trials Office

Dublin, , Ireland

Site Status

Galway Uni Hospital; Oncology Dept

Galway, , Ireland

Site Status

University Hospital Limerick - Oncology

Limerick, , Ireland

Site Status

Waterford Regional Hospital; Department Of Medical Oncology

Waterford, , Ireland

Site Status

Soroka Medical Center; Oncology Dept

Beersheba, , Israel

Site Status

Ranbam Health Care Campus; Oncology - Hafia

Hafia, , Israel

Site Status

Hadassah Ein Karem Hospital; Oncology Dept

Jerusalem, , Israel

Site Status

Chaim Sheba Medical Center; Oncology Dept

Ramat Gan, , Israel

Site Status

Istituto Tumori Giovanni Paolo II IRCSS; Ospedale Oncologico Bari

Bari, Apulia, Italy

Site Status

Istituto Nazionale Tumori Fondazione G. Pascale

Napoli, Campania, Italy

Site Status

IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola; Oncologia Medica

Meldola, Emilia-Romagna, Italy

Site Status

A.O. Universitaria Policlinico Di Modena; Oncologia

Modena, Emilia-Romagna, Italy

Site Status

AO Santa Maria Nuova; U.O. Day Hospital di Oncologi

Reggio Emilia, Emilia-Romagna, Italy

Site Status

A.O. Universitaria S. Maria Della Misericordia Di Udine; Oncologia

Udine, Friuli Venezia Giulia, Italy

Site Status

Istituto Dermopatico dell'Immacolata (IDI)-IRCCS; IV Divisione Oncologica e Dermatologia Oncologica

Rome, Lazio, Italy

Site Status

IFO - Istituto Regina Elena; Oncologia Medica

Rome, Lazio, Italy

Site Status

IRCCS Istituto Nazionale Per La Ricerca Sul Cancro (IST); Oncologia Medica A

Genoa, Liguria, Italy

Site Status

Asst Papa Giovanni XXIII; Oncologia Medica

Bergamo, Lombardy, Italy

Site Status

Az. Osp. Spedali Civili; Divisione Di Oncologia - Iii Medicina

Brescia, Lombardy, Italy

Site Status

Irccs Ospedale San Raffaele;Oncologia Medica

Milan, Lombardy, Italy

Site Status

Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2

Milan, Lombardy, Italy

Site Status

Irccs Istituto Europeo Di Oncologia (IEO); Oncologia Medica

Milan, Lombardy, Italy

Site Status

Policlinico Le Molinette; Clinica Dermatologica

Turin, Piedmont, Italy

Site Status

Policlinico P. Giaccone; Istituto Di Oncologia, Clinica Medica 1

Palermo, Sicily, Italy

Site Status

Azienda Ospedaliero-Universitaria Careggi;S.C. Oncologia Medica 1

Florence, Tuscany, Italy

Site Status

Azienda Ospedaliera S. Chiara; Dip di Onc,Trapianti e delle Nuove Tecnologie in Medicina

Pisa, Tuscany, Italy

Site Status

A.O.U. Senese Policlinico Santa Maria Alle Scotte

Siena, Tuscany, Italy

Site Status

Azienda Ospedaliera S. Maria - Terni; Oncologia

Terni, Umbria, Italy

Site Status

IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Seconda

Padua, Veneto, Italy

Site Status

Daugavpils Regional Hospital

Daugavpils, , Latvia

Site Status

Rigas Austrumu Kliniska Universitates slimnica, Latvijas Onkologijas centrs

Riga, , Latvia

Site Status

Klaipeda University Hospital

Klaipėda, , Lithuania

Site Status

Vilnius University Hospital Santariskiu Clinic, Hematology, Oncology and Tranfusion Medicine Center

Vilnius, , Lithuania

Site Status

Fundación Rodolfo Padilla Padilla, A.C.; Oncology

León, , Mexico

Site Status

Hospital General de México; Unidad de Oncologia

Mexico City, , Mexico

Site Status

Inst. Nacional de Cancerologia; Investigacion Clinica

Mexico City, , Mexico

Site Status

Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde

Amsterdam, , Netherlands

Site Status

VU MEDISCH CENTRUM; Dept. of Medical Oncology

Amsterdam, , Netherlands

Site Status

Tergooiziekenhuizen

Blaricum, , Netherlands

Site Status

Amphia Ziekenhuis

Breda, , Netherlands

Site Status

Academ Ziekenhuis Groningen; Medical Oncology

Groningen, , Netherlands

Site Status

Academisch Ziekenhuis Leiden; Clinical Oncology

Leiden, , Netherlands

Site Status

Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde

Maastricht, , Netherlands

Site Status

UMC St Radboud; Interne Oncologie; Medical Oncology Department

Nijmegen, , Netherlands

Site Status

Erasmus MC

Rotterdam, , Netherlands

Site Status

Universitair Medisch Centrum Utrecht; Inwendige Geneeskunde Afd.

Utrecht, , Netherlands

Site Status

University Clinic for Radiotherapy and Oncology Skopje; Department of skin malignancies

Skopje, , North Macedonia

Site Status

Haukeland Universitetshospital; Onkologisk Avd.

Bergen, , Norway

Site Status

The Norvegian Radium Hospital Montebello; Dept of Oncology

Oslo, , Norway

Site Status

Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology

Arequipa, , Peru

Site Status

Instituto Nacional de Enfermedades Neoplasicas

Lima, , Peru

Site Status

Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii

Krakow, , Poland

Site Status

ZOZ MSWiA z Warminsko-Mazurskim Centrum Onkologii;Wojska Polskiego 37

Olsztyn, , Poland

Site Status

NZOZ Med.-Polonia sp. z o.o.

Poznan, , Poland

Site Status

Centrum Onkologii- Instytut; im. M.Skłodowskiej-Curie

Warsaw, , Poland

Site Status

IPO de Lisboa; Servico de Oncologia Medica

Lisbon, , Portugal

Site Status

IPO do Porto; Servico de Oncologia Medica

Porto, , Portugal

Site Status

Institut of Oncology Al. Trestioreanu Bucharest; Oncology

Bucharest, , Romania

Site Status

Medisprof SRL

Cluj-Napoca, , Romania

Site Status

S.C. Life Search S.R.L; Medical Oncology Clinic

Timișoara, , Romania

Site Status

FSBI "Scientific Research Institute of Oncology named after N.N.Petrov" Ministry of Health of RF

Saint Petersburg, Sankt-Peterburg, Russia

Site Status

Regional Clinical Oncology Dispensary

Krasnodar, , Russia

Site Status

Russian Cancer Research Center

Moscow, , Russia

Site Status

Moscow city oncology hospital #62 of Moscow Healthcare Department

Moscow, , Russia

Site Status

St. Petersburg Oncology & Gynecology; City Clinical Oncology Dispensary

Saint Petersburg, , Russia

Site Status

Stavropol Clinical Oncology Dispansary

Stavropol, , Russia

Site Status

Bashkirian Republican Clinical Oncology Dispensary

Ufa, , Russia

Site Status

Institute for Oncology and Radiology of Serbia; Medical Oncology

Belgrade, , Serbia

Site Status

Clinical Center Bezanijska Kosa; Oncology

Belgrade, , Serbia

Site Status

Onkologicky ustav sv. Alzbety; Oddelenie ambulantnej chemoterapie

Bratislava, , Slovakia

Site Status

Narodny Onkologicky Ustav; Oddelenie klinickej onkologie E

Bratislava, , Slovakia

Site Status

POKO Poprad; Department of Oncology

Poprad, , Slovakia

Site Status

Institute of Oncology Ljubljana

Ljubljana, , Slovenia

Site Status

Universitas Annex, University of the Free State; Clinical Oncology

Bloemfontein, , South Africa

Site Status

Cape Town Oncology Trials

Cape Town, , South Africa

Site Status

Cancercare

Cape Town, , South Africa

Site Status

Medical Oncology Centre of Rosebank; Oncology

Johannesburg, , South Africa

Site Status

Steve Biko Academic Hospital; Oncology

Pretoria, , South Africa

Site Status

Sandton Oncology Centre

Sandton, , South Africa

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Seoul St Mary's Hospital

Seoul, , South Korea

Site Status

Seoul National University Hosp; Dept Internal Med Hem Onc

Seoul, , South Korea

Site Status

Yonsei University Severance Hospital; Medical Oncology

Seoul, , South Korea

Site Status

Asan Medical Center.

Seoul, , South Korea

Site Status

Hospital Universitario Son Espases

Palma de Mallorca, Balearic Islands, Spain

Site Status

Hospital Universitario Marques de Valdecilla; Servicio de Oncologia

Santander, Cantabria, Spain

Site Status

Complejo Hospitalario Universitario A Coruña (CHUAC, Materno Infantil), Oncología

A Coruña, La Coruña, Spain

Site Status

Hospital Universitario Materno Infantil de Gran Canaria; Servicio de Oncologia

Las Palmas de Gran Canaria, Las Palmas, Spain

Site Status

Hospital Universitario de Santa Lucía; Servicio de Oncología Médica

Cartagena (Murcia), Murcia, Spain

Site Status

Clinica Universitaria de Navarra; Servicio de Oncologia

Pamplona, Navarre, Spain

Site Status

Hospital Xeral Cíes; Servicio de Oncologia

Vigo, Pontevedra, Spain

Site Status

Hospital Univ. Central de Asturias; Servicio de Oncologia

Oviedo, Principality of Asturias, Spain

Site Status

Hospital Universitario de Canarias (HUC)

La Laguna (Tenerife), Tenerife, Spain

Site Status

Hospital de Cruces; Servicio de Oncologia

Barakaldo, Vizcaya, Spain

Site Status

Hospital Univ Vall d'Hebron; Servicio de Oncologia

Barcelona, , Spain

Site Status

Hospital Clínic i Provincial; Servicio de Hematología y Oncología

Barcelona, , Spain

Site Status

Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia

Barcelona, , Spain

Site Status

Hospital Reina Sofia

Córdoba, , Spain

Site Status

Hospital Universitario Virgen de las Nieves; Servicio de Oncologia

Granada, , Spain

Site Status

Complejo Asistencial Universitario de Leon; Servicio de Oncologia

León, , Spain

Site Status

Hospital Ramon y Cajal; Servicio de Oncologia

Madrid, , Spain

Site Status

Hospital Universitario Clínico San Carlos; Servicio de Oncologia

Madrid, , Spain

Site Status

Hospital Universitario 12 de Octubre; Servicio de Oncologia

Madrid, , Spain

Site Status

Hospital Universitario La Paz; Servicio de Oncologia

Madrid, , Spain

Site Status

Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia

Málaga, , Spain

Site Status

Hospital Regional Universitario Carlos Haya; Servicio de Oncologia

Málaga, , Spain

Site Status

Hospital Clinico Universitario de Salamanca; Servicio de Oncologia

Salamanca, , Spain

Site Status

Hospital Universitario Virgen Macarena; Servicio de Oncologia

Seville, , Spain

Site Status

Hospital General Universitario de Valencia; Servicio de oncologia

Valencia, , Spain

Site Status

Instituto Valenciano Oncologia; Oncologia Medica

Valencia, , Spain

Site Status

Hospital Universitario Miguel Servet; Servicio Oncologia

Zaragoza, , Spain

Site Status

Sahlgrenska Universitetssjukhuset; Onkology

Gothenburg, , Sweden

Site Status

Skånes Onkologiska Klinik, Universitetssjukhuset

Lund, , Sweden

Site Status

Karolinska Universitetssjukhuset, Solna

Stockholm, , Sweden

Site Status

Norrlands universitetssjukhus; Onkologkliniken

Umeå, , Sweden

Site Status

Akademiska sjukhuset, Onkologkliniken

Uppsala, , Sweden

Site Status

Universitaetsspital Basel; Onkologie

Basel, , Switzerland

Site Status

Inselspital Bern; Medizinische Onkologie

Bern, , Switzerland

Site Status

Kantonsspital Graubünden;Onkologie und Hämatologie

Chur, , Switzerland

Site Status

CHUV; Departement d'Oncologie

Lausanne, , Switzerland

Site Status

Kantonsspital St. Gallen; Onkologie/Hämatologie

Sankt Gallen, , Switzerland

Site Status

Universitätsspital Zürich; Dermatologische Klinik

Zurich, , Switzerland

Site Status

Adana Baskent University Hospital; Medical Oncology

Adana, , Turkey (Türkiye)

Site Status

Cukurova Uni Faculty of Medicine; Medical Oncology

Adana, , Turkey (Türkiye)

Site Status

Ankara Uni , Ibn-I Sina Hospital; Oncology Dept

Ankara, , Turkey (Türkiye)

Site Status

Gazi Uni Medical Faculty Hospital; Oncology Dept

Ankara, , Turkey (Türkiye)

Site Status

Akdeniz University School of Medicine; General Surgery

Antalya, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty; Medical Oncology Department

Bornova, İ̇zmi̇r, , Turkey (Türkiye)

Site Status

Gaziantep University Medical Faculty, Medical Oncology Department

Gaziantep, , Turkey (Türkiye)

Site Status

Kartal Training and Research Hospital;Medical Oncology Department

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul Uni Cerrahpasa Medical Faculty Hospital; Medical Oncology

Istanbul, , Turkey (Türkiye)

Site Status

American Hospital, Medical Oncology Department

Istanbul, , Turkey (Türkiye)

Site Status

Dokuz Eylul Uni ; Medical Oncology

Izmir, , Turkey (Türkiye)

Site Status

Hacettepe Uni Medical Faculty Hospital; Oncology Dept

Sıhhiye, Ankara, , Turkey (Türkiye)

Site Status

Addenbrookes Nhs Trust; Oncology Clinical Trials Unit

Cambridge, , United Kingdom

Site Status

Beatson West of Scotland Cancer Centre

Glasgow, , United Kingdom

Site Status

Royal Surrey County Hospital; St. Lukes Cancer Centre

Guildford, , United Kingdom

Site Status

St James University Hospital

Leeds, , United Kingdom

Site Status

Royal Marsden Hospital

London, , United Kingdom

Site Status

Christie Hospital; Breast Cancer Research Office

Manchester, , United Kingdom

Site Status

Northern Centre for Cancer Care Freeman Hospital; Sir Bobby Robson Cancer Trials Research Centre

Newcastle upon Tyne, , United Kingdom

Site Status

Mount Vernon Hospital; Centre For Cancer Treatment

Northwood, , United Kingdom

Site Status

Nottingham University Hospitals City Campus

Nottingham, , United Kingdom

Site Status

Churchill Hospital; Oxford Cancer and Haematology Centre

Oxford, , United Kingdom

Site Status

Southampton General Hospital; Medical Oncology

Southampton, , United Kingdom

Site Status

Singleton Hospital; Oncology

Swansea, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Albania Argentina Australia Austria Belgium Bosnia and Herzegovina Brazil Bulgaria Canada Colombia Croatia Czechia Denmark Ecuador Estonia Finland Germany Greece Hungary India Ireland Israel Italy Latvia Lithuania Mexico Netherlands North Macedonia Norway Peru Poland Portugal Romania Russia Serbia Slovakia Slovenia South Africa South Korea Spain Sweden Switzerland Turkey (Türkiye) United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Larkin J, Brown MP, Arance AM, Hauschild A, Queirolo P, Vecchio MD, Ascierto PA, Krajsova I, Schachter J, Neyns B, Garbe C, Sileni VC, Mandala M, Gogas H, Espinosa E, Hospers G, Lorigan P, Nyakas M, Guminski A, Liszkay G, Rutkowski P, Miller W Jr, Donica M, Makrutzki M, Blank C. An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system. Eur J Cancer. 2019 Jan;107:175-185. doi: 10.1016/j.ejca.2018.11.018. Epub 2018 Dec 20.

Reference Type DERIVED
PMID: 30580112 (View on PubMed)

Larkin J, Del Vecchio M, Ascierto PA, Krajsova I, Schachter J, Neyns B, Espinosa E, Garbe C, Sileni VC, Gogas H, Miller WH Jr, Mandala M, Hospers GA, Arance A, Queirolo P, Hauschild A, Brown MP, Mitchell L, Veronese L, Blank CU. Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study. Lancet Oncol. 2014 Apr;15(4):436-44. doi: 10.1016/S1470-2045(14)70051-8. Epub 2014 Feb 27.

Reference Type DERIVED
PMID: 24582505 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-023526-21

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

MO25515

Identifier Type: -

Identifier Source: org_study_id